NRP1 and breast carcinoma: Regarding the BMI values among breast cancer molecular subtypes, the Luminal A patients who were overweight/obese had elevated serum levels of VEGF, HB-EGF, PDGF-CC and NRP-1 when compared to the non-obese patients (p > 0.05) (Table 4) (Figure 4).